Inhibikase Therapeutics Inc (IKT)
Stock-Based Compensation
$19.96M
TTM · Period ending: · USD
IKT Stock-Based Compensation
Latest reported$19.96Mperiod ending
Latest reported$19.96Mperiod ending
IKT Stock-Based Comp ($310.09K → $19.96M)
Annual stock-based compensation
High-resolution chart · PNG
IKT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 15,309,924 | |
| 8,140,617 | |
| 500,148 | |
| 458,147 | |
| 1,531,876 | |
| 573,695 | |
| 1,436,608 | |
| 642,231 | |
| 300,659 | |
| 310,088 |